give it time
healthcare has great long term fundamentals.. and these guys have done a great job up to now. Drug policy has nothing to do with NHC ( so what happened to CXR and VRX is not relavent).. The sector has been weak but doubt it will continue to fade. 1-2 months and all this will be forgotten, other than that this was a good buying opp..